GWSG
DNA icon

GPS Wealth Strategies Group’s Ginkgo Bioworks DNA Stock Holding History

GPS Wealth Strategies Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15
Closed -$219 – 814
2025
Q3 		$219 Hold
15
– – ﹤0.01% 1578
2025
Q2 		$169 Hold
15
– – ﹤0.01% 1558
2025
Q1 		$86 Hold
15
– – ﹤0.01% 1464
2024
Q4 		$147 Hold
15
– – ﹤0.01% 1353
2024
Q3 		$122 Sell
15
-1
-6% -$10 ﹤0.01% 1367
2024
Q2 		$213 Hold
16
– – ﹤0.01% 1318
2024
Q1 		$740 Hold
16
– – ﹤0.01% 1184
2023
Q4 		$1.08K Hold
16
– – ﹤0.01% 1157
2023
Q3 		$1.16K Buy
+16
New +$1.28K ﹤0.01% 1166

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GPS Wealth Strategies Group's DNA Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 15 shares — an estimated $219 sold.

GPS Wealth Strategies Group first reported a position in DNA in Q3 2023 and held it in 9 quarters. The position peaked at $1.16K in Q3 2023. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 15 Ginkgo Bioworks shares in Q4 2025, an estimated $219.
  • GPS Wealth Strategies Group first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 9 quarters.
  • GPS Wealth Strategies Group's Ginkgo Bioworks position peaked at $1.16K in Q3 2023.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.